Arbutus Announces Corporate Update and Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Arbutus Biopharma (ABUS) Tops Q2 EPS by 9c
August 3, 2017 4:01 PM EDTArbutus Biopharma (NASDAQ: ABUS) reported Q2 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $1 million versus the consensus estimate of $590 thousand.
For earnings history and earnings-related data on Arbutus Biopharma (ABUS) click here.
... More